Company Search:
Advanced Search
Sponsored Links
Oasmia Pharmaceutical AB - ADR Company Snapshot
Oasmia Pharmaceutical AB - ADR operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB - ADR with three other pharmaceutical manufacturers in North America: CEL-SCI Corporation (2017 sales of $69,020.00 ), Sangui Biotech International, Incorporated ($67,653.00 ), and Americann Inc ($40,000.00 ).

Sales Analysis.
  Stock Performance Chart for Oasmia Pharmaceutical AB - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.12
(Figures in U.S. Dollars)
1 Week 21.8%   13 Weeks 12.0%  
4 Weeks 10.9%   52 Weeks -61.2%  
Oasmia Pharmaceutical AB - ADR Key Data:
  Ticker: OASM Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 19,601
(Year Ending Jan 2018).
Employees: 75
  Currency: U.S. Dollars Market Cap: 65,858,240
  Fiscal Yr Ends: April Shares Outstanding: 58,802,000
  Share Type: ADR Closely Held Shares: 20,781,177
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.